Nicole M Anderson Selected Research

dihydrolipoamide

6/2022	α-Ketoglutarate-Mediated DNA Demethylation Sustains T-Acute Lymphoblastic Leukemia upon TCA Cycle Targeting.
1/2021	Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole M Anderson Research Topics

Disease

6	Neoplasms (Cancer) 01/2024 - 01/2018
2	Liver Neoplasms (Liver Cancer) 01/2024 - 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Neuroblastoma 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2019
1	Lung Neoplasms (Lung Cancer) 11/2019
1	Cytopenia 01/2012

Drug/Important Bio-Agent (IBA)

2	SenotherapeuticsIBA 01/2024 - 01/2022
2	TransferasesIBA 01/2024 - 06/2022
2	dihydrolipoamideIBA 06/2022 - 01/2021
2	EnzymesIBA 01/2021 - 01/2018
1	Essential Amino AcidsIBA 01/2024
1	Methionine (L-Methionine)FDA Link 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 06/2022
1	DioxygenasesIBA 06/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	NAD (NADH)IBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	IACS-010759IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 11/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2012

Therapy/Procedure

2	Therapeutics 06/2022 - 01/2022